Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07596173

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines

Sex: All
Ages: 11 Years – 12 Years
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 90
Sponsor: GlaxoSmithKline

Location: GSK Investigational Site Fukuoka

Summary

The purpose of the study is to assess the immune response, reactogenicity and safety of a booster dose of dTpa vaccine 1 month after vaccination in healthy Japanese participants aged 11 to \

Eligibility Criteria

Inclusion Criteria: * Participants and/or participants' parent(s)/ Legally acceptable representative(s) \[LAR(s)\], who, in the opinion of the investigator, can and will comply with the requirements of the protocol. * Physical or digital informed assent obtained from the participant prior to performance of any study-specific procedure. * Physical or digital informed consent obtained from the parent(s)/LAR(s) of the participant prior to performance of any study-specific procedure. * Healthy participants as established by medical history and clinical examination at screening. * Male/female participant between and including 11 and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07596173). StuddyBuddy aggregates publicly available trial information.